Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2014 • 26,824 citations

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

2010 • 21,372 citations

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

2005 • 4,040 citations

Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone

2011 • 622 citations

Metformin and the Risk of Cancer

2012 • 480 citations

Diabetes mellitus and risk of bladder cancer: a meta-analysis

2006 • 292 citations

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study

2012 • 273 citations

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study

2012 • 264 citations

Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting

2011 • 239 citations

On the Treatment of Grouped Observations in Life Studies

1977 • 221 citations

Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis

2012 • 151 citations

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs

2012 • 140 citations

Pioglitazone and risk of bladder cancer: a meta‐analysis of controlled studies

2013 • 135 citations

Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan

2011 • 127 citations

Pioglitazone and Bladder Cancer

2011 • 121 citations

Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta‐analysis

2013 • 120 citations

Expression of peroxisome proliferator‐activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists

2003 • 102 citations

Pioglitazone and bladder cancer: a propensity score matched cohort study

2012 • 86 citations

Role of Peroxisome Proliferator-Activated Receptor γ and Its Ligands in Non-Neoplastic and Neoplastic Human Urothelial Cells

2001 • 84 citations

Effects of Pioglitazone, a Peroxisome Proliferator–Activated Receptor Gamma Agonist, on the Urine and Urothelium of the Rat

2009 • 78 citations

Diabetes and risk of bladder cancer

2010 • 77 citations

Risk of Bladder Cancer in Diabetic Patients Treated with Rosiglitazone or Pioglitazone: A Nested Case–Control Study

2013 • 67 citations

Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: A meta-analysis

2012 • 63 citations

A Review on Thiazolidinediones and Bladder Cancer in Human Studies

2014 • 37 citations

The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone

2012 • 34 citations

Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes

2012 • 33 citations

Pioglitazone use and the risk of bladder cancer

2013 • 32 citations

Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer

2014 • 27 citations

Rosiglitazone is not associated with an increased risk of bladder cancer

2013 • 19 citations

Pioglitazone and bladder cancer – Authors' reply

2011 • 6 citations

Pathology of bladder cancer among diabetic patients undergoing radical cystectomy with a history of pioglitazone (Actos) use

2014 • 5 citations